アナプラスティックリンパ腫キナーゼ受容体の活性化メカニズム
Andrey V Reshetnyak1, Paolo Rossi1, Alexander G Myasnikov1
1Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Nature
|November 25, 2021
まとめ
ALKAL1/ 2リガンドによるアナプラスティックリンパ腫キナーゼ (ALK) 受容体の活性化にはユニークなメカニズムが含まれています. 構造研究は,ALK受容体の二分化と活性化がどのように起こるかを明らかにし,多様な受容体チロシンキナーゼ活性化経路を強調しています.
科学分野:
- 構造生物学
- 分子細胞生物学
- 生物化学
背景:
- アナプラスティックリンパ腫キナーゼ (ALK) は,中枢神経系機能に不可欠な受容体チロシンキナーゼ (RTK) である.
- 転位と変異を含むALK遺伝子の変異は,様々なヒトがん,特に小児神経芽細胞腫に関連しています.
- ALKの細胞外領域 (ECR) の構造データがないため,そのリガンド (ALK1/ 2) によるALK活性化の理解は限られている.
研究 の 目的:
- ALKAL1 と ALKAL2 リガンドによるヒトALK二重化と活性化の原子詳細を解明する.
- ALK受容体の活性化メカニズムの構造的基礎を理解する.
主な方法:
- 電子冷凍顕微鏡 (EM冷凍)
- 核磁共振 (NMR) スペクトロスコーピー
- X線結晶学
主要な成果:
- ALKAL1とALKAL2との複合体におけるヒトALKの原子構造を決定した.
- ダイメリック (ALKAL2) とモノメリック (ALKAL1) リガンドの両方に対応する新しいRTK活性化メカニズムを明らかにした.
- リガンド誘発によるALK-ECRの膜並列方向への再配置が実証され,リガンド-膜相互作用によって安定した.
結論:
- この研究は,ALKの活性化を誘発する異常な受容体-リガンド複合体の構造を発見した.
- 発見は,受容体チロシンキナーゼのオリゴメリゼーションと活性化における構造的多様性を強調しています.
- 癌生物学に関連するALKシグナル伝達経路に関する重要な洞察を提供します.
関連する概念動画
Amplifying Signals via Enzymatic Cascade
13.3K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
13.3K
Receptor Tyrosine Kinases
15.0K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.0K
PI3K/mTOR/AKT Signaling Pathway
4.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.1K
MAPK Signaling Cascades
6.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.5K
Enzyme-linked Receptors
80.6K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
80.6K
The JAK-STAT Signaling Pathway
9.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.6K


